Pink SheetVinay Prasad, the US Food and Drug Administration’s new director of the Center for Biologics Evaluation and Research, said his role in product reviews will be no different than previous center directo
Pink SheetConfused and alarmed stakeholders worry that Health and Human Services Secretary Robert F. Kennedy Jr. usurped a role long played by the US Centers for Disease Control and Prevention and its external
Pink SheetContract manufacturing of biologics is one of the few weak points in the typically overwhelming advantage the US holds over Europe in bestowing the first approval for new drug products, a Pink Sheet
Pink SheetThe US Food and Drug Administration’s vaccine advisors split on whether COVID-19 vaccine manufacturers should update shots with a new strain for the 2025-2026 vaccine season, as uncertainty about the